Biosplice Therapeutics, Inc.
Clinical trials sponsored by Biosplice Therapeutics, Inc., explained in plain language.
-
Could a single shot slow knee arthritis? early trial halted
Disease control TerminatedThis study tested an experimental injection called lorecivivint for people with painful knee osteoarthritis. The main goal was to see if the injection could improve the health of knee cartilage, measured by MRI scans over one year. The trial was small and ended early due to COVID…
Phase: PHASE2 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Two-Year trial tests new shot for Worn-Out knees
Disease control TerminatedThis study followed people with knee osteoarthritis to see if an experimental drug called lorecivivint was safe and helpful over two years. All 276 participants had been in a previous study and received injections into their knee. The goal was to see if the drug could reduce pain…
Phase: PHASE3 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC